Greenwich LifeSciences Inc.
GLSI | NASDAQ
$14.65
-$1.70 (-10.40%)
At close: Nov 5, 2026, 4:00 PM ET
$15.23
+$0.58 (+3.96%)
After-hours:
Nov 5, 2026, 5:04 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -14.69 | -9.28 | -15.25 | -24.92 | -69.51 | -243.13 |
PEG Ratio | -0.81 | -0.12 | -1.16 | -0.34 | -0.52 | 5.04 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 805.09 | 160.85 | 20.17 | 14.85 | 11.74 | 16.77 |
P/FCF Ratio | -28.69 | -20.11 | -20.86 | -31.66 | -73.38 | -401.83 |
P/OCF Ratio | -28.69 | -20.11 | -20.86 | -31.66 | -73.38 | -401.83 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | 0.01 |
Quick Ratio | 1.06 | 1.28 | 23.74 | 51.23 | 70.63 | 27.41 |
Current Ratio | 1.06 | 1.28 | 23.74 | 51.23 | 70.63 | 27.41 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -5.48K% | -1.92K% | -132.71% | -59.22% | -17.03% | -6.74% |
Return on Assets | -313.34% | -425.38% | -127.12% | -58.06% | -16.79% | -6.49% |
Return on Invested Capital | -5.51K% | -1.94K% | -139.21% | -60.85% | -17.14% | -6.68% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove GLSI